STAT recently published our op-ed: State drug importation laws undermine the process that keeps our supply chain safe.
I co-authored this op-ed with Dirk Rodgers, an independent consultant and author of the excellent RxTrace blog.
As we see it, there is no legal or operational way of transforming a drug packaged for a foreign market into a drug that meets the U.S. requirements of our in-progress track-and-trace system. What’s more, there is no way to alter the law to enable importation without undermining the law’s purpose and value.
States can't wish away the requirements of a significant federal law. Either we have a secure drug supply chain or we don’t.
Note that our op-ed was published before Canada announced that it would resist drug exportation.
Full text below. Read on and let us know what you think.
Read more »
Source: Post feed
